Thyrocare Technologies Limited
ITI Mutual Fund bought 4,01,000 shares of Thyrocare Technologies for ₹25.02 Cr at ₹624.00 apiece in a block deal. Shares of Thyrocare Technologies saw significant trading activity, with over 8% of its equity changing hands in block deals totaling ₹821.72 crore on this day.
A healthcare diagnostics provider, Thyrocare Technologies operates a network of diagnostic centers across India delivering laboratory testing and pathology services. The company partners with hospitals, clinics, and independent laboratories to offer affordable diagnostic solutions to patients nationwide. Its distinctive approach combines technology-enabled operations with cost-effective service delivery, making quality diagnostic care accessible across urban and semi-urban markets in India.
Independent AMC backed by institutional investors, founded by former Reliance MF and Birla executives. Manages over Rs 5,000 crore. ITI Multi-Cap Fund and ITI Long Term Equity Fund are its flagship equity offerings. Positions itself as a boutique, research-driven equity house with strong fundamental analysis capabilities.